Protafan HM vials 100 IU / ml, 10 ml (insulin isophan human genetically Inzhenernyi)
Special Price
$23.80
Regular Price
$28.00
In stock
SKU
newyork494215
Release form
suspension for subcutaneous administration Buy Protafan HM vials 100 IU / ml, 10 ml (insulin isophan human genetically Inzhenernyi) in newyork free shipping. Fast international shipping USA, AU, EU, UK and others.
suspension for subcutaneous administration Buy Protafan HM vials 100 IU / ml, 10 ml (insulin isophan human genetically Inzhenernyi) in newyork free shipping. Fast international shipping USA, AU, EU, UK and others.
Release form
suspension for subcutaneous administration
Packing
1 bottle 10 ml.
Pharmacological action
Hypoglycemic. Protafan HM interacts with a specific plasma membrane receptor and penetrates the cell, where it activates the phosphorylation of cellular proteins, stimulates glycogen synthetase, pyruvate dehydrogenase, hexokinase, and inhibits adipose tissue lipase and lipoprotein lipase. In combination with a specific receptor, it facilitates the penetration of glucose into cells, enhances its uptake by tissues and promotes conversion to glycogen. Increases muscle glycogen supply, stimulates peptide synthesis.
Indications
Type I diabetes mellitus, type II diabetes mellitus (with resistance to sulfonylurea derivatives, intercurrent diseases, operations and in the postoperative period, during pregnancy).
Contraindications
Hypoglycemia, insulinoma.
Composition
Active ingredient: insulin-isophan (human genetic engineering)
Auxiliary substances: zinc chloride glycerin (glycerol) metacresol phenol sodium hydrogen phosphate protamine dihydrate sodium sulfate hydroxide and / or hydrochloric acid (for pH adjustment) water for injection
Dosage and Administration
Subcutaneous. The drug is intended for subcutaneous administration. Suspensions of insulin cannot be administered iv.
The dose of the drug is selected individually, taking into account the needs of the patient. Typically, insulin requirements are between 0.3 and 1 IU / kg / day. The daily requirement for insulin may be higher in patients with insulin resistance (for example, during puberty, as well as in patients with obesity), and lower in patients with residual endogenous insulin production.
ProtafanВ® NM can be used both in monotherapy and in combination with quick or short acting insulin.
ProtafanВ® HM is usually administered subcutaneously in the thigh. If this is convenient, then injections can also be done in the anterior abdominal wall, in the gluteal region or in the region of the deltoid muscle of the shoulder. With the introduction of the drug into the thigh area, more Typically, insulin requirements are between 0.3 and 1 IU / kg / day. The daily requirement for insulin may be higher in patients with insulin resistance (for example, during puberty, as well as in patients with obesity), and lower in patients with residual endogenous insulin production.
ProtafanВ® NM can be used both in monotherapy and in combination with quick or short acting insulin.
ProtafanВ® HM is usually administered subcutaneously in the thigh. If this is convenient, then injections can also be done in the anterior abdominal wall, in the gluteal region or in the region of the deltoid muscle of the shoulder. With the introduction of the drug into the thigh area, more Typically, insulin requirements are between 0.3 and 1 IU / kg / day. The daily requirement for insulin may be higher in patients with insulin resistance (for example, during puberty, as well as in patients with obesity), and lower in patients with residual endogenous insulin production.
ProtafanВ® NM can be used both in monotherapy and in combination with quick or short acting insulin.
ProtafanВ® HM is usually administered subcutaneously in the thigh. If this is convenient, then injections can also be done in the anterior abdominal wall, in the gluteal region or in the region of the deltoid muscle of the shoulder. With the introduction of the drug into the thigh area, more and lower in patients with residual endogenous insulin production.
ProtafanВ® NM can be used both in monotherapy and in combination with quick or short acting insulin.
ProtafanВ® HM is usually administered subcutaneously in the thigh. If this is convenient, then injections can also be done in the anterior abdominal wall, in the gluteal region or in the region of the deltoid muscle of the shoulder. With the introduction of the drug into the thigh area, more and lower in patients with residual endogenous insulin production.
ProtafanВ® NM can be used both in monotherapy and in combination with quick or short acting insulin.
ProtafanВ® HM is usually administered subcutaneously in the thigh. If this is convenient, then injections can also be done in the anterior abdominal wall, in the gluteal region or in the region of the deltoid muscle of the shoulder. With the introduction of the drug into the thigh area, moreslow absorption than when introduced into other areas. If the injection is made into an extended skin fold, the risk of accidental intramuscular administration of the drug is minimized.
The needle should remain under the skin for at least 6 seconds, which guarantees a full dose. It is necessary to constantly change the injection site within the anatomical region to prevent the development of lipodystrophy.
ProtafanВ® NM PenfillВ® is designed for use with Novo Nordisk insulin injection systems and NovoFineВ® or NovoTvistВ® needles. Detailed recommendations for the use and administration of the drug should be observed.
Dose adjustment
Concomitant diseases, especially infectious and accompanied by fever, usually increase the body's need for insulin. Dose adjustment may also be required if the patient has concomitant diseases of the kidneys, liver, impaired adrenal function, pituitary gland or thyroid gland. The need for dose adjustment can also arise when changing physical activity or the patient's usual diet. Dose adjustment may be required when transferring a patient from one type of insulin to another
Side effects
Hypoglycemic conditions, allergic reactions, lipodystrophy (with prolonged use).
Drug interactions
Acetylsalicylic acid, alcohol, alpha and beta adrenoblockers, amphetamine, anabolic steroids, clofibrate, cyclophosphamide, phenfluramine, weakly trofamide, inhibitor tetrafamide, methylphosphamide, inhibitor trifoxamide, inhibitor trifoxamide, enhances the hypoformide, phosphorfamide, chlorofetamide, phosphorfamide, chlorofetamide, inhibitor tetrafamide, phosphoformide, inhibitor tetraphenolate, diazoxide, diuretics (especially thiazides), glucocorticoids, heparin, hormonal contraceptives, isoniazid, lithium carbonate, nicotinic acid, phenothiazines, sympathomimetics, tricyclic e antidepressants.
Overdose
Symptoms: development of hypoglycemia (cold sweat, palpitations, tremors, hunger, agitation, irritability, pallor, headache, drowsiness, lack of movement, speech and vision impairment, depression). Severe hypoglycemia can lead to temporary or permanent impairment of brain function, coma, and death.
Treatment: sugar or glucose solution inside (if the patient is conscious), s / c, i / m or iv - glucagon or iv - glucose.
Storage conditions
In a dark place at a temperature of 2-8 ° C (do not freeze). Store the vial used at room temperature not higher than 30 ° C for 6 weeks. Protect from heat and sunlight.
Deystvuyuschee substances
Insulin-yzofan chelovecheskyy genetically Inzhenernyi
Conditions of release from
pharmacies Prescription
dosage form
suspension for injection
Protafan HM vials 100 IU / ml, 10 ml (insulin isophan human genetically Inzhenernyi) newyork in pharmacy online. Cheap price, instruction, side effects, dosage. Protafan HM vials 100 IU / ml, 10 ml - Sale. PayPal accept. Free shipping newyork. Fast international shipping.
suspension for subcutaneous administration
Packing
1 bottle 10 ml.
Pharmacological action
Hypoglycemic. Protafan HM interacts with a specific plasma membrane receptor and penetrates the cell, where it activates the phosphorylation of cellular proteins, stimulates glycogen synthetase, pyruvate dehydrogenase, hexokinase, and inhibits adipose tissue lipase and lipoprotein lipase. In combination with a specific receptor, it facilitates the penetration of glucose into cells, enhances its uptake by tissues and promotes conversion to glycogen. Increases muscle glycogen supply, stimulates peptide synthesis.
Indications
Type I diabetes mellitus, type II diabetes mellitus (with resistance to sulfonylurea derivatives, intercurrent diseases, operations and in the postoperative period, during pregnancy).
Contraindications
Hypoglycemia, insulinoma.
Composition
Active ingredient: insulin-isophan (human genetic engineering)
Auxiliary substances: zinc chloride glycerin (glycerol) metacresol phenol sodium hydrogen phosphate protamine dihydrate sodium sulfate hydroxide and / or hydrochloric acid (for pH adjustment) water for injection
Dosage and Administration
Subcutaneous. The drug is intended for subcutaneous administration. Suspensions of insulin cannot be administered iv.
The dose of the drug is selected individually, taking into account the needs of the patient. Typically, insulin requirements are between 0.3 and 1 IU / kg / day. The daily requirement for insulin may be higher in patients with insulin resistance (for example, during puberty, as well as in patients with obesity), and lower in patients with residual endogenous insulin production.
ProtafanВ® NM can be used both in monotherapy and in combination with quick or short acting insulin.
ProtafanВ® HM is usually administered subcutaneously in the thigh. If this is convenient, then injections can also be done in the anterior abdominal wall, in the gluteal region or in the region of the deltoid muscle of the shoulder. With the introduction of the drug into the thigh area, more Typically, insulin requirements are between 0.3 and 1 IU / kg / day. The daily requirement for insulin may be higher in patients with insulin resistance (for example, during puberty, as well as in patients with obesity), and lower in patients with residual endogenous insulin production.
ProtafanВ® NM can be used both in monotherapy and in combination with quick or short acting insulin.
ProtafanВ® HM is usually administered subcutaneously in the thigh. If this is convenient, then injections can also be done in the anterior abdominal wall, in the gluteal region or in the region of the deltoid muscle of the shoulder. With the introduction of the drug into the thigh area, more Typically, insulin requirements are between 0.3 and 1 IU / kg / day. The daily requirement for insulin may be higher in patients with insulin resistance (for example, during puberty, as well as in patients with obesity), and lower in patients with residual endogenous insulin production.
ProtafanВ® NM can be used both in monotherapy and in combination with quick or short acting insulin.
ProtafanВ® HM is usually administered subcutaneously in the thigh. If this is convenient, then injections can also be done in the anterior abdominal wall, in the gluteal region or in the region of the deltoid muscle of the shoulder. With the introduction of the drug into the thigh area, more and lower in patients with residual endogenous insulin production.
ProtafanВ® NM can be used both in monotherapy and in combination with quick or short acting insulin.
ProtafanВ® HM is usually administered subcutaneously in the thigh. If this is convenient, then injections can also be done in the anterior abdominal wall, in the gluteal region or in the region of the deltoid muscle of the shoulder. With the introduction of the drug into the thigh area, more and lower in patients with residual endogenous insulin production.
ProtafanВ® NM can be used both in monotherapy and in combination with quick or short acting insulin.
ProtafanВ® HM is usually administered subcutaneously in the thigh. If this is convenient, then injections can also be done in the anterior abdominal wall, in the gluteal region or in the region of the deltoid muscle of the shoulder. With the introduction of the drug into the thigh area, moreslow absorption than when introduced into other areas. If the injection is made into an extended skin fold, the risk of accidental intramuscular administration of the drug is minimized.
The needle should remain under the skin for at least 6 seconds, which guarantees a full dose. It is necessary to constantly change the injection site within the anatomical region to prevent the development of lipodystrophy.
ProtafanВ® NM PenfillВ® is designed for use with Novo Nordisk insulin injection systems and NovoFineВ® or NovoTvistВ® needles. Detailed recommendations for the use and administration of the drug should be observed.
Dose adjustment
Concomitant diseases, especially infectious and accompanied by fever, usually increase the body's need for insulin. Dose adjustment may also be required if the patient has concomitant diseases of the kidneys, liver, impaired adrenal function, pituitary gland or thyroid gland. The need for dose adjustment can also arise when changing physical activity or the patient's usual diet. Dose adjustment may be required when transferring a patient from one type of insulin to another
Side effects
Hypoglycemic conditions, allergic reactions, lipodystrophy (with prolonged use).
Drug interactions
Acetylsalicylic acid, alcohol, alpha and beta adrenoblockers, amphetamine, anabolic steroids, clofibrate, cyclophosphamide, phenfluramine, weakly trofamide, inhibitor tetrafamide, methylphosphamide, inhibitor trifoxamide, inhibitor trifoxamide, enhances the hypoformide, phosphorfamide, chlorofetamide, phosphorfamide, chlorofetamide, inhibitor tetrafamide, phosphoformide, inhibitor tetraphenolate, diazoxide, diuretics (especially thiazides), glucocorticoids, heparin, hormonal contraceptives, isoniazid, lithium carbonate, nicotinic acid, phenothiazines, sympathomimetics, tricyclic e antidepressants.
Overdose
Symptoms: development of hypoglycemia (cold sweat, palpitations, tremors, hunger, agitation, irritability, pallor, headache, drowsiness, lack of movement, speech and vision impairment, depression). Severe hypoglycemia can lead to temporary or permanent impairment of brain function, coma, and death.
Treatment: sugar or glucose solution inside (if the patient is conscious), s / c, i / m or iv - glucagon or iv - glucose.
Storage conditions
In a dark place at a temperature of 2-8 ° C (do not freeze). Store the vial used at room temperature not higher than 30 ° C for 6 weeks. Protect from heat and sunlight.
Deystvuyuschee substances
Insulin-yzofan chelovecheskyy genetically Inzhenernyi
Conditions of release from
pharmacies Prescription
dosage form
suspension for injection
Protafan HM vials 100 IU / ml, 10 ml (insulin isophan human genetically Inzhenernyi) newyork in pharmacy online. Cheap price, instruction, side effects, dosage. Protafan HM vials 100 IU / ml, 10 ml - Sale. PayPal accept. Free shipping newyork. Fast international shipping.
Submit your review to Earn 10 Reward Points click here to login
Write Your Own Review